Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | 225Ac-PSMA-617 |
| Trade Name | |
| Synonyms | AAA817|[225Ac]Ac-PSMA-617|Actinium Ac 225 vipivotide tetraxetan |
| Drug Descriptions |
225Ac-PSMA-617 is a 225Ac-labeled PSMA-targeting ligand that may inhibit growth of PSMA-expressing tumors (PMID: 27390158). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C219072 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| 225Ac-PSMA-617 | 225Ac-PSMA-617 | 0 | 0 |
| 225Ac-PSMA-617 + Abiraterone | 225Ac-PSMA-617 Abiraterone | 0 | 0 |
| 225Ac-PSMA-617 + Cabazitaxel | 225Ac-PSMA-617 Cabazitaxel | 0 | 0 |
| 225Ac-PSMA-617 + Docetaxel | 225Ac-PSMA-617 Docetaxel | 0 | 0 |
| 225Ac-PSMA-617 + Enzalutamide | 225Ac-PSMA-617 Enzalutamide | 0 | 0 |